Heramed Ltd (HMD) - Total Liabilities

Latest as of June 2025: AU$658.25K AUD ≈ $465.75K USD

Based on the latest financial reports, Heramed Ltd (HMD) has total liabilities worth AU$658.25K AUD (≈ $465.75K USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore HMD operating cash flow to assess how effectively this company generates cash.

Heramed Ltd - Total Liabilities Trend (2016–2024)

This chart illustrates how Heramed Ltd's total liabilities have evolved over time, based on quarterly financial data. Check how resilient are Heramed Ltd's assets to evaluate the company's liquid asset resilience ratio.

Heramed Ltd Competitors by Total Liabilities

The table below lists competitors of Heramed Ltd ranked by their total liabilities.

Company Country Total Liabilities
Enerside Energy S.A.
MC:ENRS
Spain €82.41 Million
M.J. International Co Ltd
TW:8466
Taiwan NT$3.42 Billion
Tela Bio Inc
NASDAQ:TELA
USA $60.03 Million
Rightmove PLC
LSE:RMV
UK GBX45.88 Million
Jubilee Enterprise Public Company Limited
BK:JUBILE
Thailand ฿453.17 Million
Career Point Limited
NSE:CAREERP
India Rs932.47 Million
Ginni Filaments Limited
NSE:GINNIFILA
India Rs862.14 Million
Fusemachines Inc. Common stock
NASDAQ:FUSE
USA $43.91 Million

Liability Composition Analysis (2016–2024)

This chart breaks down Heramed Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Heramed Ltd stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 3.04 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 1.74 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.63 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Heramed Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Heramed Ltd (2016–2024)

The table below shows the annual total liabilities of Heramed Ltd from 2016 to 2024.

Year Total Liabilities Change
2024-12-31 AU$1.06 Million
≈ $750.21K
-31.49%
2023-12-31 AU$1.55 Million
≈ $1.10 Million
+19.51%
2022-12-31 AU$1.30 Million
≈ $916.32K
-68.67%
2021-12-31 AU$4.13 Million
≈ $2.92 Million
+247.71%
2020-12-31 AU$1.19 Million
≈ $841.06K
-2.30%
2019-12-31 AU$1.22 Million
≈ $860.89K
+32.78%
2018-12-31 AU$916.32K
≈ $648.35K
-12.38%
2017-12-31 AU$1.05 Million
≈ $739.99K
+22.28%
2016-12-31 AU$855.26K
≈ $605.15K
--

About Heramed Ltd

AU:HMD Australia Medical Devices
Market Cap
$39.40 Million
AU$55.68 Million AUD
Market Cap Rank
#22729 Global
#858 in Australia
Share Price
AU$0.05
Change (1 day)
+2.04%
52-Week Range
AU$0.01 - AU$0.05
All Time High
AU$0.32
About

HeraMED Limited, a medical data and technology company, develops, manufactures, and sells home-based maternity monitoring technology in Australia and the United States. It also provides HeraBEAT, a medical device for fetal and maternal heart rate used by pregnant women; and HeraCARE, a remote fetal heart rate monitoring solution. The company has a collaboration agreement with Mayo Clinic for the … Read more